ORIGINAL STUDIES |
|
Mussabay K.N., Vinogradova E.A., Dusmagambetov M.U., Bekbosynova M.S., Tauekelova A.T., Kozhakhmetov S.S., Kushugulova A.R.
Dynamic changes of cytokines in COVID-19 and in the post-COVID period
|
8-18 |
|
Kudryavtseva N.A., Chorbinskaya S.A., Devyatkin A.V., Samushiya M.A., Kolpakov E.A., Kuznetsov A.I., Shchepkina E.V.
Development of a predicative model of the threat of COVID- 19 unfavorable outcome in hospitalized patients of older age groups by means of artificial intelligence use
|
19-27 |
|
Tereshkin N.A., Makashova V.V., Ponezheva Zh.B., Omarova Kh.G., Muzyka A.D., Gorelov A.V.
Prognostic value of serum biomarkers in case of chronic hepatitis C
|
28-34 |
|
Gurovskikh A.V., Grigorovich M.S.
Estimation of the efficacy of probiotic cocktails in correcting intestinal microbial-tissue barrier and subjective well-being of convalescents who have survived mild forms of COVID-19
|
35-42 |
|
Kadnikov L.I., Izmozherova N.V., Popov A.A., Antropova I.P.
Estimation of the platelet component of hemostasis in COVID-19 patients
|
43-49 |
|
Ponezheva L.O., Turapova A.N., Mannanova I.V., Alakaev R.Z., Vyzhlova E.N., Bragina G.S., Kalyuzhin O.V.
Clinical and immunological peculiarities of ARVI in patients with concomitant allergic rhinitis in remission
|
50-57 |
|
Gappoeva E.T.
Experience of using mometasone in seasonal allergic rhinitis patients
|
58-62 |
|
Tayutina T.V., Shlyk S.V.
Diagnostic value of systemic inflammation and endothelial dysfunction markers in the formation of chronic obstructive pulmonary disease clinical phenotypes
|
64-72 |
|
Chulkov V.S., Okonenko T.I., Khrutsky A.K., Zhmaylova S.V.
Cost of medicamentous therapy and clinical characteristics of patients with late stage rheumatoid arthritis and arterial hypertension
|
74-80 |
|
Tanashyan M.M., Maksimova M.Yu., Lagoda O.V.
Treatment adherence in patients after orthognathic surgery
|
81-87 |
REVIEWS |
|
Startseva M.A., Malinnikova E.Yu.
Viral hepatitis E in immunosuppressed patients
|
88-95 |
|
Kasimova A.R., Tufanova O.S.
Use of apixaban for prevention of a secondary brain stroke in patients with atrial fibrillation
|
96-104 |
|
Malimon V.V., Kokorin V.A.
Antihypertensive therapy in a patient with metabolic syndrome
|
105-112 |
|
Bilevich O.A., Loginova E.N., Druk I.V., Chernykh D.A.
Prevalence of chronic kidney disease in the countries worldwide
|
114-120 |
GUIDELINES FOR PRACTITIONERS |
|
Vasiliev V.V., Markin I.V., Rogozina N.V., Skripchenko N.V.
Cytomegalovirus infection during pregnancy period
|
121-128 |
|
Karpenko D.G., Lukyanova E.A., Ponomareva A.V., Larina V.N.
Clinical observation of a patient with severe malaria clinical course in outpatient conditions
|
129-138 |
|
Eremina E.Yu., Strokova O.A., Zvereva S.I.
Patient with primary systemic amyloidosis: A difficult way to diagnosis
|
139-144 |
LECTURES & REPORTS |
|
Krupin M.G., Bliznyuk S.A., Zhegalina A.S., Komarova A.G., Rodionov E.P., Ploskireva A.A.
Cardiac complications in sepsis
|
145-153 |
|
Ostroumova O.D., Dubinina A.V., Telkova S.S., Gavrilova N.E., Sinitsina I.I., Malyavin A.G.
Pathogenesis of virus-induced inflammation: From theory to development and implementation of a new paradigm of medicinal remedies
|
154-164 |
Activities of RNMOT |
|
Digest of interregional scientific and practical events under the aegis or with the participation of RSMSIM (September 2024)
|
165-168 |
WE REMEMBER |
|
Kokorin V.A., Romashevskaya E.I.
To the 125th anniversary of the birth of P.E. Lukomsky
|
170-175 |
Русский
